MEGAN KANN: Open Payments
NPI 1568852721 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 32 payments from 15 companies in 2025. Trend: 2023 $995 · 2024 $461 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 7 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $141 |
| Orthofix Medical, Inc. | 1 | $86 |
| Neurelis, Inc. | 5 | $82 |
| ACADIA Pharmaceuticals Inc | 4 | $56 |
| CSL Behring | 2 | $33 |
| Integra LifeSciences Corporation | 1 | $30 |
| Lilly USA, LLC | 1 | $23 |
| Merz Pharmaceuticals, LLC | 1 | $21 |
| TG Therapeutics, Inc. | 1 | $20 |
Products named: HYQVIA, Spinal-Stim, VALTOCO, NUPLAZID, Briviact, Rystiggo, Zilbrysq, Hizentra.
Industry payments across FL — which companies pay providers there.
